Gotham Asset Management’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$748K Sell
62,200
-83,897
-57% -$989K ﹤0.01% 1505
2026
Q2
$1.56M Buy
146,097
+90,226
+161% +$697K ﹤0.01% 1228
2026
Q1
$356K Sell
55,871
-18,969
-25% -$132K ﹤0.01% 1569
2025
Q4
$527K Buy
74,840
+724
+1% +$4.37K ﹤0.01% 1423
2025
Q3
$408K Buy
74,116
+26,587
+56% +$130K ﹤0.01% 1428
2025
Q2
$246K Buy
47,529
+15,601
+49% +$93.5K ﹤0.01% 1518
2025
Q1
$213K Buy
+31,928
New +$243K ﹤0.01% 1456

Other funds holding LFST

Gotham Asset Management's LFST Position: Q3 2026 in Review

Gotham Asset Management reduced its Lifestance Health (LFST) stake by 57% in Q3 2026, selling an estimated $989K and leaving 62,200 shares worth $748K. The position accounts for ﹤0.01% of the portfolio, ranked #1505.

Gotham Asset Management first reported a position in LFST in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.56M in Q2 2026. 324 funds tracked by Wall St. Rank hold LFST as of Q3 2026.

  • Gotham Asset Management held 62,200 shares of Lifestance Health worth $748K as of Q3 2026.
  • Gotham Asset Management sold 83,897 Lifestance Health shares in Q3 2026, an estimated $989K.
  • Lifestance Health made up ﹤0.01% of Gotham Asset Management's portfolio in Q3 2026, its #1505 holding.
  • Gotham Asset Management first reported a position in Lifestance Health in Q1 2025 and has held it in 7 quarters since.
  • Gotham Asset Management's Lifestance Health position peaked at $1.56M in Q2 2026.
  • 324 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2026.

Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.